BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19112083)

  • 1. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
    Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2009 Mar; 63(3):520-5. PubMed ID: 19112083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.
    Thanissery R; Winston JA; Theriot CM
    Anaerobe; 2017 Jun; 45():86-100. PubMed ID: 28279860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and Stress Resistances of
    Edwards AN; Karim ST; Pascual RA; Jowhar LM; Anderson SE; McBride SM
    Front Microbiol; 2016; 7():1698. PubMed ID: 27833595
    [No Abstract]   [Full Text] [Related]  

  • 4. A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against
    Thanissery R; Zeng D; Doyle RG; Theriot CM
    Front Microbiol; 2018; 9():1206. PubMed ID: 29928268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loratadine is an anti-inflammatory agent against C. difficile toxin B.
    Xie Y; Irwin S; Chupina Estrada A; Nelson B; Bullock A; Fontenot L; Feng H; Sun M; Koon HW
    J Infect Dis; 2024 Jan; ():. PubMed ID: 38243838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of
    Yang J; Yang H
    Front Microbiol; 2018; 9():2953. PubMed ID: 30564210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing
    Anonye BO; Hassall J; Patient J; Detamornrat U; Aladdad AM; Schüller S; Rose FRAJ; Unnikrishnan M
    Front Microbiol; 2019; 10():879. PubMed ID: 31114553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins.
    Paredes-Sabja D; Shen A; Sorg JA
    Trends Microbiol; 2014 Jul; 22(7):406-16. PubMed ID: 24814671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pH-responsive SmrR-SmrT system modulates
    Wetzel D; Carter ZA; Monteiro MP; Edwards AN; Scharer CD; McBride SM
    Infect Immun; 2024 Mar; 92(3):e0046123. PubMed ID: 38345371
    [No Abstract]   [Full Text] [Related]  

  • 11. A sporulation signature protease is required for assembly of the spore surface layers, germination and host colonization in Clostridioides difficile.
    Marini E; Olivença C; Ramalhete S; Aguirre AM; Ingle P; Melo MN; Antunes W; Minton NP; Hernandez G; Cordeiro TN; Sorg JA; Serrano M; Henriques AO
    PLoS Pathog; 2023 Nov; 19(11):e1011741. PubMed ID: 37956166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of the intestinal microbiome-a slow journey to primetime.
    Kriger-Sharabi O; Malnick SDH; Fisher D
    World J Clin Cases; 2023 Jul; 11(21):4975-4988. PubMed ID: 37583860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic perturbations to the gut microbiome.
    Fishbein SRS; Mahmud B; Dantas G
    Nat Rev Microbiol; 2023 Dec; 21(12):772-788. PubMed ID: 37491458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity, Dynamics and Therapeutic Application of
    Nale JY; Thanki AM; Rashid SJ; Shan J; Vinner GK; Dowah ASA; Cheng JKJ; Sicheritz-Pontén T; Clokie MRJ
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560776
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of antibiotic resistance of Clostridioides difficile.
    Wickramage I; Spigaglia P; Sun X
    J Antimicrob Chemother; 2021 Nov; 76(12):3077-3090. PubMed ID: 34297842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic Homopolymers Inhibit Spore and Vegetative Cell Growth of
    Jones JB; Liu L; Rank LA; Wetzel D; Woods EC; Biok N; Anderson SE; Lee MR; Liu R; Huth S; Sandhu BK; Gellman SH; McBride SM
    ACS Infect Dis; 2021 May; 7(5):1236-1247. PubMed ID: 33739823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-on-a-chip: Current progress and future opportunities.
    Ashammakhi N; Nasiri R; Barros NR; Tebon P; Thakor J; Goudie M; Shamloo A; Martin MG; Khademhosseini A
    Biomaterials; 2020 Oct; 255():120196. PubMed ID: 32623181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.
    Carlson TJ; Blasingame D; Gonzales-Luna AJ; Alnezary F; Garey KW
    Anaerobe; 2020 Apr; 62():102142. PubMed ID: 32007682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-Loaded Nanoparticles Enhance Sporicidal and Antibacterial Efficacy for
    Chen YH; Li TJ; Tsai BY; Chen LK; Lai YH; Li MJ; Tsai CY; Tsai PJ; Shieh DB
    Front Microbiol; 2019; 10():1141. PubMed ID: 31178844
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.